Cargando…
KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483082/ https://www.ncbi.nlm.nih.gov/pubmed/37691862 http://dx.doi.org/10.21037/tlcr-23-271 |
| _version_ | 1785102301955883008 |
|---|---|
| author | Chen, Hao Yumoto, Kentaro Kashizaki, Fumihiro Koizumi, Harumi Ikeda, Ichiro Horita, Nobuyuki Takahashi, Kenichi Kaneko, Takeshi |
| author_facet | Chen, Hao Yumoto, Kentaro Kashizaki, Fumihiro Koizumi, Harumi Ikeda, Ichiro Horita, Nobuyuki Takahashi, Kenichi Kaneko, Takeshi |
| author_sort | Chen, Hao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104830822023-09-08 KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer Chen, Hao Yumoto, Kentaro Kashizaki, Fumihiro Koizumi, Harumi Ikeda, Ichiro Horita, Nobuyuki Takahashi, Kenichi Kaneko, Takeshi Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-07-19 2023-08-30 /pmc/articles/PMC10483082/ /pubmed/37691862 http://dx.doi.org/10.21037/tlcr-23-271 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Chen, Hao Yumoto, Kentaro Kashizaki, Fumihiro Koizumi, Harumi Ikeda, Ichiro Horita, Nobuyuki Takahashi, Kenichi Kaneko, Takeshi KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title | KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title_full | KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title_fullStr | KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title_full_unstemmed | KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title_short | KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| title_sort | keynote-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483082/ https://www.ncbi.nlm.nih.gov/pubmed/37691862 http://dx.doi.org/10.21037/tlcr-23-271 |
| work_keys_str_mv | AT chenhao keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT yumotokentaro keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT kashizakifumihiro keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT koizumiharumi keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT ikedaichiro keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT horitanobuyuki keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT takahashikenichi keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer AT kanekotakeshi keynote407aneffectiveandsafefirstlinetreatmentoptionformetastaticsquamousnonsmallcelllungcancer |